ACADIA Pharmaceuticals Statistics
NASDAQ: ACADHealth CareBiotechnology: Pharmaceutical PreparationsUSD
19.65-0.09 (-0.46%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 19.80 +0.75%
ACADIA Pharmaceuticals by the numbers
ACADIA Pharmaceuticals has a market capitalization of $3.39 billion based on 172.31M shares outstanding. Its trailing P/E ratio is 8.8, and its forward P/E is 22.1. The stock trades 26.2% below its 50-day average and 19.1% below its 200-day average.
Average daily trading volume is 1.84M shares, or about $36.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ACAD valuation vs. peer median
| Metric | ACAD | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.39B | $3.59B | -6% |
| Avg. volume | 1.84M | 2.34M | -21% |
Peer median across 8 companies: AMLX, IDYA, XENE, PBLS, OGN, VKTX, TNGX, LEGN.
Valuation
- Market cap
- $3.39B
- P/E (TTM)
- 8.81
- Forward P/E
- 22.12
- Price / sales (latest FY)
- 3.16
- EPS (TTM)
- $2.23
- Shares outstanding
- 172.31M
Price and trading
- Previous close
- 19.74
- Open
- 19.60
- Day range
- 19.46 – 19.80
- 52-week range
- 19.46 – 30.96
- 52-week change
- -8.77%
- Beta
- —
- Volume
- 1.78M
- Average volume
- 1.84M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 3.39B
- Pe
- 8.81
- Forward Pe
- 22.12
- Eps
- 2.23
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 30.96
- Week52 Low
- 19.46
- Avg Volume
- 1.84M
- Shares Outstanding
- 172.31M
- Ma50
- 26.62
- Ma200
- 24.29
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -36.53%
- Pct From52w Low
- 0.98%